1.A Case of Endovascular Repair of Iatrogenic Arterial Injury with an Aberrant Right Subclavian Artery
Jun Osaki ; Junji Yunoki ; Atsutoshi Tanaka ; Hiroaki Yamamoto ; Hisashi Sato ; Hiroyuki Morokuma ; Keiji Kamohara ; Koujiro Furukawa ; Shigeki Morita
Japanese Journal of Cardiovascular Surgery 2014;43(6):318-321
A 61-year-old man underwent percutaneous coronary intervention (PCI) for the right coronary artery. However, he had an acute onset of right neck pain and swelling after PCI. Contrast enhanced computed tomography (CT) revealed extravasation into the mediastinum and aberrant right subclavian artery. After transfer to our hospital, we performed emergency endovascular repair for iatrogenic arterial injury. His postoperative course was uneventful.
2.A Case of Central Diabetes Insipidus Who Underwent Open Heart Surgery
Shizuka Yaita ; Ryo Noguchi ; Keiji Kamohara ; Junji Yunoki ; Hiroyuki Morokuma ; Shugou Koga ; Atuhisa Tanaka ; Koujiro Furukawa ; Shigeki Morita
Japanese Journal of Cardiovascular Surgery 2016;45(6):277-280
Central diabetes insipidus (CDI) is a disease that caused by insufficient or no anti-diuretic hormone (ADH) secretion from the posterior pituitary, which results in an increase in urine volume. CDI is controlled with ADH supplementation thereby reducing urine output and correcting electrolyte imbalance. However, reports on perioperative management for CDI patient are scarce, especially for patients who underwent cardiac surgery. We herein report our experience of the management of a CDI patient who underwent surgery for valvular heart disease.
The case is a 72-year-old woman who developed secondary CDI after pituitary tumor removal. She had been controlled with orally administered desmopressin acetate hydrochloride. She underwent aortic valve replacement and mitral valve repair for severe aortic, and moderate mitral regurgitation. Immediately after surgery, we started vasopressin div, which yielded good urine volume control. However, once we started to switch vasopressin to oral desmopressin administration, the control became worse. We thus made a sliding scale for subcutaneous injection of vasopressin every 8 h according to the amount of urine output, which resulted in good control. Overlapping administration of vasopressin and oral desmopressin between postoperative day 12 and 17 resulted in successful transition. The patient was discharged with oral desmopressin administration. Management with sliding scale for vasopressin subcutaneous injection after surgery was useful in controlling a CDI patient who underwent major cardiac surgery.
3.Leadless Pacemaker Implantation Following Transcatheter Aortic Valve Implantation Using SAPIEN 3
Taku SHIKAMA ; Mizuki MIURA ; Shinichi SHIRAI ; Masaomi HAYASHI ; Junji MORITA ; Michio NAGASHIMA ; Kenji ANDO
Korean Circulation Journal 2018;48(6):534-535
No abstract available.
Transcatheter Aortic Valve Replacement